Adaptimmune Therapeutics
ADAP
#8446
Rank
โ‚น13.14 B
Marketcap
โ‚น51.37
Share price
0.82%
Change (1 day)
23.53%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น20.16 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's total liabilities are โ‚น20.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adaptimmune Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น20.23 B-1%
2022-12-31โ‚น20.44 B4.2%
2021-12-31โ‚น19.61 B144.06%
2020-12-31โ‚น8.03 B94.67%
2019-12-31โ‚น4.12 B97.83%
2018-12-31โ‚น2.08 B-58.18%
2017-12-31โ‚น4.99 B7.41%
2016-12-31โ‚น4.64 B
2015-06-30โ‚น2.65 B-16.76%
2014-06-30โ‚น3.18 B1250.37%
2013-06-30โ‚น0.23 B4%
2012-06-30โ‚น0.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น190.14 B 842.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.51 B-87.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.10 B 148.47%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น58.16 B 188.43%๐Ÿ‡บ๐Ÿ‡ธ USA